Author Correction: Sorcin can trigger pancreatic cancer-associated new-onset diabetes through the secretion of inflammatory cytokines such as serpin E1 and CCL5.

Saved in:
Bibliographic Details
Title: Author Correction: Sorcin can trigger pancreatic cancer-associated new-onset diabetes through the secretion of inflammatory cytokines such as serpin E1 and CCL5.
Authors: Gong J; Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.; Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Cancer Institute, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.; Cancer Center, Zhejiang University, Hangzhou, Zhejiang, China.; Department of Surgery, Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang, China., Li X; Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.; Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Cancer Institute, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.; Cancer Center, Zhejiang University, Hangzhou, Zhejiang, China.; Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA., Feng Z; Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.; Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Cancer Institute, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.; Cancer Center, Zhejiang University, Hangzhou, Zhejiang, China., Lou J; Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.; Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Cancer Institute, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.; Cancer Center, Zhejiang University, Hangzhou, Zhejiang, China., Pu K; Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.; Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Cancer Institute, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.; Cancer Center, Zhejiang University, Hangzhou, Zhejiang, China., Sun Y; Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.; Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Cancer Institute, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.; Cancer Center, Zhejiang University, Hangzhou, Zhejiang, China.; Department of Surgery, Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang, China., Hu S; Department of Surgery, Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang, China., Zhou Y; Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.; Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Cancer Institute, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.; Cancer Center, Zhejiang University, Hangzhou, Zhejiang, China., Song T; Department of Surgery, Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang, China., Shangguan M; Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.; Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Cancer Institute, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.; Cancer Center, Zhejiang University, Hangzhou, Zhejiang, China., Zhang K; School of Public Health and Eye Center The Second Affiliated Hospital, Zhejiang University, Hangzhou, China., Lu W; Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.; Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Cancer Institute, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.; Cancer Center, Zhejiang University, Hangzhou, Zhejiang, China., Dong X; Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.; Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Cancer Institute, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.; Cancer Center, Zhejiang University, Hangzhou, Zhejiang, China., Wu J; Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.; School of Public Health, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.; Institute of Wenzhou, Zhejiang University, Wenzhou, Zhejiang, China., Zhu H; Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.; Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China.; Center for Drug Safety Evaluation and Research of Zhejiang University, Hangzhou, Zhejiang, China., He Q; Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. qiaojunhe@zju.edu.cn.; Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China. qiaojunhe@zju.edu.cn.; Center for Drug Safety Evaluation and Research of Zhejiang University, Hangzhou, Zhejiang, China. qiaojunhe@zju.edu.cn., Xu H; Innovation Institute for Artificial Intelligence in Medicine and Liangzhu Laboratory, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China. Einstein@zju.edu.cn., Wu Y; Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. yulianwu@zju.edu.cn.; Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Cancer Institute, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. yulianwu@zju.edu.cn.; Cancer Center, Zhejiang University, Hangzhou, Zhejiang, China. yulianwu@zju.edu.cn.; Department of Surgery, Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang, China. yulianwu@zju.edu.cn.
Source: Experimental & molecular medicine [Exp Mol Med] 2024 Nov; Vol. 56 (11), pp. 2549.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 9607880 Publication Model: Print Cited Medium: Internet ISSN: 2092-6413 (Electronic) Linking ISSN: 12263613 NLM ISO Abbreviation: Exp Mol Med Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2092-6413
DOI:10.1038/s12276-024-01363-3